Evidence map›Paper›PMID 41102690›Full record

ArticleBMC public health2025

Self-reported poliomyelitis vaccination and documentation in adults indicates high uptake: a digital German epidemic panel, December 2024.

Robyn Kettlitz, Manuela Harries, Seba Contreras, Jannik Reinecke, Maren Sophia Wieder, Thomas von Lengerke, Stefanie Castell, Berit Lange, Carolina J Klett-Tammen, PCR-4-ALL study group and 1 more

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Robyn KettlitzDepartment of Epidemiology, Helmholtz Centre for Infection Research, Brunswick, Lower Saxony, Germany.
Manuela HarriesDepartment of Epidemiology, Helmholtz Centre for Infection Research, Brunswick, Lower Saxony, Germany.
Seba ContrerasMax Planck Institute for Dynamics and Self-Organization, Göttingen, Germany.
Jannik ReineckeDepartment of Epidemiology, Helmholtz Centre for Infection Research, Brunswick, Lower Saxony, Germany.
Maren Sophia WiederDepartment of Epidemiology, Helmholtz Centre for Infection Research, Brunswick, Lower Saxony, Germany.
Thomas von LengerkeHannover Medical School, Department of Medical Psychology, Hannover, Germany.
Stefanie CastellDepartment of Epidemiology, Helmholtz Centre for Infection Research, Brunswick, Lower Saxony, Germany.
Berit LangeDepartment of Epidemiology, Helmholtz Centre for Infection Research, Brunswick, Lower Saxony, Germany.
Carolina J Klett-TammenDepartment of Epidemiology, Helmholtz Centre for Infection Research, Brunswick, Lower Saxony, Germany. carolina.klett-tammen@helmholtz-hzi.de.
PCR-4-ALL study group
MuSPAD study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOn 12 December 2024, the Standing Committee on Vaccination (STIKO) recommended universal polio catch-up vaccination for children and adolescents up to 16, urging parents to check their children's immunization status following detections of vaccine-derived poliovirus in wastewater. The Robert Koch Institute (RKI) also advised healthcare professionals to ensure vaccination coverage in priority groups. Regional health authorities, called on all citizens to review their vaccination records to address any immunization gaps. We investigated vaccine uptake (documented / recalled) to improve estimates of immunity against poliovirus among the German population and gain insights into the proportion of undocumented vaccines.

methodsWe conducted a survey in December 2024 using the eResearch System PIA (Prospective Monitoring and Management-App) to collect data on self-reported vaccine uptake among a German cohort. We calculated the frequency of vaccinations that were documented and undocumented, as well as the types of vaccines and the number of doses received. Vaccination status was classified as received ≤ 2 doses versus ≥ 3 doses of any polio-containing vaccine. We applied survey weights to calculate frequencies according the general German population (by age, sex, region) and logistic regression to examine the relationships between the vaccinations that were not documented but recalled, and the factors associated with these undocumented vaccinations.

resultsAmong 1,124 participants who completed the survey on vaccination uptake, 1,097 (96.9%) participants stated to have a vaccination record. A total of 823/1,124 (74.3%) reported having a vaccination record, where at least one poliomyelitis vaccine was documented, whereas 233 (19.0%) participants recalled at least one poliomyelitis vaccination without documentation or vaccination record. Of 1,124, 68 participants (6.7%) did not report any polio vaccination neither documented nor recalled without documentation. Among the 823 participants with documented vaccination and at least one vaccination, 592 (75.1%) received at least three doses of a poliomyelitis vaccine, with a decline in older age groups, less than three doses were reported by 164 (17.6%), and the remaining 7.3% (n = 67) did not have information on the number of doses administered. Of 2,768 documented vaccine doses, 898 (29.9%) were oral poliovirus vaccines (OPV) and 704 (26.2%) were inactivated poliovirus vaccines (IPV). In 1,166 vaccines (43.9%), the type could not be derived by the participants from the vaccination record. The odds of having a recalled vaccination (not documented) was higher in male and the older age groups compared to females and younger participants. DISCUSSION: We found similar poliomyelitis vaccination uptake compared to other data sources e.g., of the Robert Koch Institute (RKI). Vaccine-derived immunity to poliomyelitis may be underestimated based on vaccination records only. There is a need to address potential gaps in health literacy and vaccination documentation. Efforts should be made to conduct continuous seroprevalence surveys in the population in response to emerging public health threats and deduce parameters to inform modelling infection dynamics in specific outbreak scenarios.

trial registrationThe PCR-4-ALL cohort was registered in the German Clinical Trials Register on the 3rd of September 2024 (DRKS00034763).

Indexed as

DocumentationPoliomyelitisPoliovirus VaccinesSelf ReportVaccinationVaccination CoverageAdolescentAdultAgedChildFemaleGermanyHumansInfantMaleMiddle AgedPoliovirus VaccinesDigital epidemiologyInfectious diseasesPoliomyelitisPopulation immunityVaccination recordsVaccination uptake

Identifiers

PMID41102690
PMCPMC12532904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.